TY - JOUR
T1 - A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice
AU - Hölter, Sabine M.
AU - Stromberg, Mary
AU - Kovalenko, Marina
AU - Garrett, Lillian
AU - Glasl, Lisa
AU - Lopez, Edith
AU - Guide, Jolene
AU - Götz, Alexander
AU - Hans, Wolfgang
AU - Becker, Lore
AU - Rathkolb, Birgit
AU - Rozman, Jan
AU - Schrewed, Anja
AU - Klingenspor, Martin
AU - Klopstock, Thomas
AU - Schulz, Holger
AU - Wolf, Eckhard
AU - Wursta, Wolfgang
AU - Gillis, Tammy
AU - Wakimoto, Hiroko
AU - Seidman, Jonathan
AU - MacDonald, Marcy E.
AU - Cotman, Susan
AU - Gailus-Durner, Valérie
AU - Fuchs, Helmut
AU - De Angelis, Martin Hrabě
AU - Lee, Jong Min
AU - Wheeler, Vanessa C.
PY - 2013/11/22
Y1 - 2013/11/22
N2 - Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG trinucleotide repeat in the HTT gene encoding huntingtin. The disease has an insidious course, typically progressing over 10-15 years until death. Currently there is no effective disease-modifying therapy. To better understand the HD pathogenic process we have developed genetic HTT CAG knock-in mouse models that accurately recapitulate the HD mutation in man. Here, we describe results of a broad, standardized phenotypic screen in 10-46 week old heterozygous HdhQ111 knock-in mice, probing a wide range of physiological systems. The results of this screen revealed a number of behavioral abnormalities in HdhQ111/+ mice that include hypoactivity, decreased anxiety, motor learning and coordination deficits, and impaired olfactory discrimination. The screen also provided evidence supporting subtle cardiovascular, lung, and plasma metabolite alterations. Importantly, our results reveal that a single mutant HTT allele in the mouse is sufficient to elicit multiple phenotypic abnormalities, consistent with a dominant disease process in patients. These data provide a starting point for further investigation of several organ systems in HD, for the dissection of underlying pathogenic mechanisms and for the identification of reliable phenotypic endpoints for therapeutic testing.
AB - Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG trinucleotide repeat in the HTT gene encoding huntingtin. The disease has an insidious course, typically progressing over 10-15 years until death. Currently there is no effective disease-modifying therapy. To better understand the HD pathogenic process we have developed genetic HTT CAG knock-in mouse models that accurately recapitulate the HD mutation in man. Here, we describe results of a broad, standardized phenotypic screen in 10-46 week old heterozygous HdhQ111 knock-in mice, probing a wide range of physiological systems. The results of this screen revealed a number of behavioral abnormalities in HdhQ111/+ mice that include hypoactivity, decreased anxiety, motor learning and coordination deficits, and impaired olfactory discrimination. The screen also provided evidence supporting subtle cardiovascular, lung, and plasma metabolite alterations. Importantly, our results reveal that a single mutant HTT allele in the mouse is sufficient to elicit multiple phenotypic abnormalities, consistent with a dominant disease process in patients. These data provide a starting point for further investigation of several organ systems in HD, for the dissection of underlying pathogenic mechanisms and for the identification of reliable phenotypic endpoints for therapeutic testing.
UR - http://www.scopus.com/inward/record.url?scp=84894379134&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0080923
DO - 10.1371/journal.pone.0080923
M3 - Article
C2 - 24278347
AN - SCOPUS:84894379134
SN - 1932-6203
VL - 8
JO - PLoS ONE
JF - PLoS ONE
IS - 11
M1 - e80923
ER -